Goldman Sachs
APTX

Goldman Sachs’s Aptinyx Inc. Common Stock APTX Stock Holding History

Goldman Sachs’s Portfolio APTX Stock Details APTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,342
Closed -$7K – 6712
2022
Q2 		$7K Sell
12,342
-37,305
-75% -$30K ﹤0.01% 6311
2022
Q1 		$112K Buy
49,647
+4,553
+10% +$13.6K ﹤0.01% 6075
2021
Q4 		$121K Buy
45,094
+2,194
+5% +$5.28K ﹤0.01% 6085
2021
Q3 		$100K Sell
42,900
-13,828
-24% -$35.2K ﹤0.01% 5908
2021
Q2 		$161K Buy
56,728
+16,832
+42% +$47K ﹤0.01% 5828
2021
Q1 		$120K Sell
39,896
-6,510
-14% -$23.4K ﹤0.01% 5787
2020
Q4 		$160K Buy
46,406
+2,006
+5% +$6.99K ﹤0.01% 5168
2020
Q3 		$150K Buy
44,400
+1,851
+4% +$7.09K ﹤0.01% 5005
2020
Q2 		$177K Sell
42,549
-59,621
-58% -$202K ﹤0.01% 4835
2020
Q1 		$221K Buy
102,170
+41,063
+67% +$134K ﹤0.01% 4658
2019
Q4 		$209K Sell
61,107
-3,744
-6% -$12.9K ﹤0.01% 4873
2019
Q3 		$226K Buy
64,851
+392
+0.6% +$1.41K ﹤0.01% 4782
2019
Q2 		$215K Buy
64,459
+29,718
+86% +$106K ﹤0.01% 4760
2019
Q1 		$141K Buy
34,741
+13,417
+63% +$97.2K ﹤0.01% 4874
2018
Q4 		$353K Buy
+21,324
New +$505K ﹤0.01% 4556
2018
Q3 		– Sell
-64,301
Closed -$1.55M – 5851
2018
Q2 		$1.55M Buy
+64,301
New +$1.38M ﹤0.01% 3785

Other funds holding APTX

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs's APTX Position: Q3 2022 in Review

Goldman Sachs sold out of Aptinyx Inc. Common Stock (APTX) in Q3 2022, closing a stake of 12,342 shares — an estimated $7K sold.

Goldman Sachs first reported a position in APTX in Q2 2018 and held it in 16 quarters. The position peaked at $1.55M in Q2 2018. 40 funds tracked by Wall St. Rank hold APTX as of Q3 2022.

  • Goldman Sachs reported no remaining Aptinyx Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Goldman Sachs sold 12,342 Aptinyx Inc. Common Stock shares in Q3 2022, an estimated $7K.
  • Goldman Sachs first reported a position in Aptinyx Inc. Common Stock in Q2 2018 and held it in 16 quarters.
  • Goldman Sachs's Aptinyx Inc. Common Stock position peaked at $1.55M in Q2 2018.
  • 40 funds tracked by Wall St. Rank held Aptinyx Inc. Common Stock as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.